Metformin treatment decreased the gene expression of Hif-1α and Socs-3, genes associated with cancer cell resistance to death [24, 25], in B16F10 cells (Figure 2C); these genes have been reported as targets of metformin in different tumor types [25, 26]. The gene discussed is HIF1A; the disease is neoplasm.